SF 1098 (see companion bill HF 1246) – Minnesota

Status: Enacted
Year Introduced: 2019
Link: https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF1098&ssn=0&y=2019

Prescription Drug Pricing Transparency Act. This bill requires drug manufacturers to report specified information on drug prices and costs to the commissioner of health, for prescription drugs whose price increases exceed certain limits, and for new prescription drugs and newly acquired prescription drugs whose price exceeds certain dollar thresholds. The bill also directs the commissioner to post certain information on drug prices and report annually to the legislature on issues related to drug pricing and spending.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found